Belgium Pharmaceuticals and Healthcare Report Q3 2012Business Monitor International
June 5, 2012
87 Pages - SKU: BMI3931238
More Prescription Drugs reports by Business Monitor International
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Sudan will remain one of the least attractive countries in the Middle East/Africa region due tolow pharmaceutical and healthcare expenditure. The government's low ...
Pakistan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Increased longevity in developed markets translates into an increased demand for aged carehealthcare services and medicines. However, in emerging markets such as Pakistan, ...
Japan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Japan remains the most attractive market in the Asia Pacific, due to the ageing and affluentpopulation and strong regulatory conditions. In particular, we ...
Croatia Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor InternationalSee all reports like this >>
Executive SummaryBMI View: Croatia's entrance into the EU will accelerate its economic liberalisation and the developmentof the country's private sector. It is also likely to ...
More Belgium Prescription Drugs reports
Belgium Pharmaceuticals and Healthcare Report Q2 2013 by Business Monitor International
BMI View: Our forecast sees the Belgian pharmaceutical market contracting over the next three years,only returning to year-on-year (y-o-y) growth in 2015. We have based ...
Antibiotics Market in Belgium to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Belgium. The study provides essential market ...
TreatmentTrends®: Bone and Mineral Metabolism (Belgium & The Netherlands) 2012 by Decision Resources
This is a new report covering the treatment of dialysis patients and mid-late stage CKD (Stage 3 / Stage 4) patients in Belgium and the ...
The Pharmaceutical Market: Belgium by Espicom Healthcare IntelligenceSee all reports like this >>
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of ...
More Belgium reports
D&B Country RiskLine Report: Belgium by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Belgium: Country Profile by MarketLine
INTRODUCTIONThis report provides a detailed analysis on Belgium, providing an overview of its political, economic and business environments, represented in textual, graph and tabular formats. ...
2007 Belgium Industry & Market Outlook report by Barnes ReportsSee all reports like this >>
The 2007 Belgium Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in Belgium and 500+ minor industries ...
We can help you find what you need. Call us or write us:
Need help in your search?
- Hospitals & Clinics
- Country Overviews
- Life Sciences
- Country Overviews
- Manufacturing, Packaging & Detailing
- Over-the-Counter Drugs
- Prescription Drugs
Prescription Drugs Reports